A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults
Clinical trial NCT05901636 · COMPLETED
Trial details
- NCT number
- NCT05901636
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-17
- Primary completion
- 2024-08-19
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.